FOXP3 and chronic obstructive pulmonary disease: Data regarding the quantification of CD4+CD25+Foxp3+ (Figure 9A) and CD4+CD25+IL10+ (Figure 9B) T lymphocytes in BAL showed a significant reduction in the COPD group compared to the basal group and an increase in the PBM treated group.